Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 882

Similar articles for PubMed (Select 17122512)

1.

Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: its histopathologic difference between 2 major types.

Ban S, Naitoh Y, Mino-Kenudson M, Sakurai T, Kuroda M, Koyama I, Lauwers GY, Shimizu M.

Am J Surg Pathol. 2006 Dec;30(12):1561-9.

PMID:
17122512
2.

Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an "intestinal" pathway of carcinogenesis in the pancreas.

Adsay NV, Merati K, Basturk O, Iacobuzio-Donahue C, Levi E, Cheng JD, Sarkar FH, Hruban RH, Klimstra DS.

Am J Surg Pathol. 2004 Jul;28(7):839-48.

PMID:
15223952
3.
4.

[Diagnosis and differential diagnosis of intraductal papillary mucinous neoplasm of pancreas].

Ji Y, Tan YS, Zhu XZ, Zeng HY, Kuang TT, Jin DY.

Zhonghua Bing Li Xue Za Zhi. 2006 Feb;35(2):77-81. Chinese.

PMID:
16630480
5.

Intraductal papillary mucinous neoplasm of the pancreas: cytologic features predict histologic grade.

Michaels PJ, Brachtel EF, Bounds BC, Brugge WR, Pitman MB.

Cancer. 2006 Jun 25;108(3):163-73.

6.

Characteristic clinicopathological features of the types of intraductal papillary-mucinous neoplasms of the pancreas.

Ishida M, Egawa S, Aoki T, Sakata N, Mikami Y, Motoi F, Abe T, Fukuyama S, Sunamura M, Unno M, Moriya T, Horii A, Furukawa T.

Pancreas. 2007 Nov;35(4):348-52.

PMID:
18090241
7.

Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype.

Ideno N, Ohtsuka T, Kono H, Fujiwara K, Oda Y, Aishima S, Ito T, Ishigami K, Tokunaga S, Ohuchida K, Takahata S, Nakamura M, Mizumoto K, Tanaka M.

Ann Surg. 2013 Jul;258(1):141-51. doi: 10.1097/SLA.0b013e31828cd008.

PMID:
23532108
8.

New classification of pancreatic intraductal papillary-mucinous tumour by mucin expression: its relationship with potential for malignancy.

Nakamura A, Horinouchi M, Goto M, Nagata K, Sakoda K, Takao S, Imai K, Kim YS, Sato E, Yonezawa S.

J Pathol. 2002 Jun;197(2):201-10.

PMID:
12015744
9.

Mucin gene expression in intraductal papillary-mucinous pancreatic tumours and related lesions.

Terris B, Dubois S, Buisine MP, Sauvanet A, Ruszniewski P, Aubert JP, Porchet N, Couvelard A, Degott C, Fléjou JF.

J Pathol. 2002 Aug;197(5):632-7.

PMID:
12210083
10.

Intraductal papillary-mucinous neoplasms of the pancreas: an analysis of in situ and invasive carcinomas in 28 patients.

Adsay NV, Conlon KC, Zee SY, Brennan MF, Klimstra DS.

Cancer. 2002 Jan 1;94(1):62-77.

PMID:
11815961
11.

Current understanding of precursors to pancreatic cancer.

Takaori K.

J Hepatobiliary Pancreat Surg. 2007;14(3):217-23. Epub 2007 May 29. Review.

PMID:
17520195
13.

Intraductal papillary mucinous neoplasm (IPMN) of the gastric-type with focal nodular growth of the arborizing papillae: a case of high-grade transformation of the gastric-type IPMN.

Ban S, Naitoh Y, Ogawa F, Shimizu Y, Shimizu M, Yasumoto A, Koyama I.

Virchows Arch. 2006 Jul;449(1):112-6. Epub 2006 Apr 26.

PMID:
16639605
14.

Intraductal papillary-mucinous neoplasms of the gastric and intestinal types may have less malignant potential than the pancreatobiliary type.

Takasu N, Kimura W, Moriya T, Hirai I, Takeshita A, Kamio Y, Nomura T.

Pancreas. 2010 Jul;39(5):604-10. doi: 10.1097/MPA.0b013e3181c6947a.

PMID:
20124938
15.

Management of intraductal papillary-mucinous neoplasm of the pancreas: treatment strategy based on morphologic classification.

Serikawa M, Sasaki T, Fujimoto Y, Kuwahara K, Chayama K.

J Clin Gastroenterol. 2006 Oct;40(9):856-62.

PMID:
17016145
16.

Comparison between mucinous cystic neoplasm and intraductal papillary mucinous neoplasm of the branch duct type of the pancreas with respect to expression of CD10 and cytokeratin 20.

Nishigami T, Onodera M, Torii I, Sato A, Tao LH, Kushima R, Kakuno A, Kishimoto M, Katsuyama E, Fujimori T, Hirano H, Satake M, Kuroda N, Nishiguchi S, Fujimoto J, Tsujimura T.

Pancreas. 2009 Jul;38(5):558-64. doi: 10.1097/MPA.0b013e31819f3bd6.

PMID:
19287335
17.

The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms.

Yonezawa S, Nakamura A, Horinouchi M, Sato E.

J Hepatobiliary Pancreat Surg. 2002;9(3):328-41.

PMID:
12353144
18.

REG4 is associated with carcinogenesis in the 'intestinal' pathway of intraductal papillary mucinous neoplasms.

Nakata K, Nagai E, Ohuchida K, Aishima S, Hayashi A, Miyasaka Y, Yu J, Mizumoto K, Tanaka M, Tsuneyoshi M.

Mod Pathol. 2009 Mar;22(3):460-8. doi: 10.1038/modpathol.2008.205. Epub 2009 Jan 9.

19.

Frequency of subtypes of biliary intraductal papillary mucinous neoplasm and their MUC1, MUC2, and DPC4 expression patterns differ from pancreatic intraductal papillary mucinous neoplasm.

Sclabas GM, Barton JG, Smyrk TC, Barrett DA, Khan S, Kendrick ML, Reid-Lombardo KM, Donohue JH, Nagorney DM, Que FG.

J Am Coll Surg. 2012 Jan;214(1):27-32. doi: 10.1016/j.jamcollsurg.2011.09.025. Epub 2011 Nov 23.

PMID:
22112419
20.

S100P is a novel marker to identify intraductal papillary mucinous neoplasms.

Nakata K, Nagai E, Ohuchida K, Hayashi A, Miyasaka Y, Aishima S, Oda Y, Mizumoto K, Tanaka M, Tsuneyoshi M.

Hum Pathol. 2010 Jun;41(6):824-31. doi: 10.1016/j.humpath.2009.11.007. Epub 2010 Feb 12.

PMID:
20153506
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk